new glp-1 drug Considering drugs for weight loss? Advice from a doctor who's used them : NPR New GLP-1 drugs could suppress

Think of it as metabolic insurance, not a performance enhancer

(Medicare Policy Initiative) Pilot programs: There have been reports that experiments or pilot programs are being considered to allow Medicare and Medicaid to better cover GLP-1s for obesity (possibly starting 2026/2027) in certain states or under certain conditions

At Saffron & Sage, this is approached through clinically directed protocols that are integrated into a broader model of care

4.9 Select All of the above-mentioned CVOTs were conducted in patients with risk factors for or diagnosed CVD with comorbid T2DM

Annals of nutrition & metabolism 2019

( a ) Schematic of BDH1- and OXCT1-mediated ketolysis